– New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engager and Phagocytosis Platform to discover first-in-class ...

BOSTON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it has entered into a ...

We now know what Bianca Censori’s BIO POP (THE ORIGIN) is, and furniture does play a key part after all. Thursday (Dec. 11), Censori launched the previously teased project in Seoul, revealing—as had ...

Curi Bio’s ribbon cutting in April 2025 for its new headquarters on Seattle’s waterfront. Elliot Fisher, co-founder and chief business officer, cuts the ribbon with a sword while CEO Nicholas Geisse ...

Pithy yet powerful, the Instagram bio can turn a casual scroller into an engaged follower—or send them straight to the back button. Let’s dive into the do’s and don’ts of crafting a bio that actually ...

Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Bio-Rad Third Quarter 2025 ...

With a new approach to creating thymus-targeted medicines for autoimmune diseases, Zag Bio has emerged from stealth with the help of backing from pharma giants AbbVie, Regeneron and Sanofi. The trio ...

This collaboration is a major step in BIO-key’s expansion across the Nordic region. The deal aims to deliver GDPR-compliant and scalable IAM technologies to strengthen identity protection and secure ...

“She totally missed everything, the truth of who I am, what my impact is,” Paltrow told British Vogue about Odell’s biography, noting that she did not personally read it but her husband, Brad Falchuk, ...

Onego Bio says its animal-free, precision-fermented Bioalbumen is functionally identical to the protein found in chicken egg whites, and is gearing up for large-scale production following FDA’s ‘no ...

Bluebird bio has molted to reveal a new—or new-ish, at least—brand identity. After a busy summer that saw the drugmaker sell itself to a pair of private equity firms, go private and install new ...